Bioabsorbable Stents Market By Application (Coronary Artery Diseases, Peripheral Artery Diseases), By Material (Polymeric Stents, Metallic Stents), By End User (Hospitals, Ambulatory Surgical Centers) - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025

Despite the advent of conventional stents as a major breakthrough in the treatment of peripheral artery disease and coronary artery disease, these devices permanently remain in the body. Issues with the implantation of conventional stents include but are not limited to mechanical blockages, malposition, late restenosis, and so on. A key prediction for interventional cardiology coming from cardiologists and their respective associations is that bioabsorbable stents will eventually replace conventional bare metal stents. Though dissolving stents have certain drawbacks compared to metallic stents, it is expected that these challenges will soon be resolved with rapid technological advances. This growth will be further substantiated by the growth in clinical data reporting the benefits of bioresorbable stents outweighing the current drawbacks.

The purpose of this research study titled "Bioabsorbable Stents Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global bioabsorbable stents market. This report presents and analyses the major trends prevalent in the global market for bioabsorbable stents, as well as the market's size and forecast.

This report categorizes the global bioabsorbable stents market in terms of material, applications, end-users, and geographical distribution. Polymeric and metallic are the basic segments of the global bioabsorbable stent market in terms of materials. Based on application types, the global bioabsorbable stents market is categorized into coronary artery diseases and peripheral artery diseases. Additionally, hospitals and ambulatory surgical centers are the end-users considered for the purpose of this study. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global bioabsorbable stents market is best understood by categorizing it into five major regions and five major region-level markets, as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Each considered geographical market's market size and forecast are presented for the period 2015-2025, along with CAGRs for the forecast period 2017-2025, and are further cross-sectional presented in terms of material, application, end-user, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global bioabsorbable stent market. Competition assessment tools such as Porter's five forces model, market attractiveness assessment, and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global bioabsorbable stent market. The key players profiled in this report are Abbott Laboratories, Arterial Remodeling Technologies, Arterius Limited, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Kyoto Medical Planning Co., Ltd., Medtronic plc, Microport Scientific Corporation, REVA Medical, Inc., STENTYS SA, and Terumo Corporation.

For the purpose of this study, the global market for bioabsorbable stents is studied for the following material types:

  1. Polymeric Stents
  2. Metallic Stents

Polymeric bioabsorbable stents are currently experiencing higher demand in treating cardiovascular diseases. Polymers such as poly-L-lactic acid, polyglycolic acid, and polycaprolactone are conventionally used in the production of polymer-based stents. Among these, poly-L-lactic acid is most commonly used in medicine, and it breaks down lactic acid into natural metabolites, thus enhancing the absorption characteristics of the implant. The use of bioabsorbable polymer coatings is generating wide acceptance due to their potential to reduce the need for dual anti-platelet therapies and avoid the risk of thrombosis. It is also expected that metallic bioabsorbable will witness growth in demand through the forecast period. Iron and magnesium are the prime metals used for making metallic bioabsorbable stents.

Higher malleability of iron and magnesium alloys, a better understanding of iron's properties and mechanisms in the body in terms of solubility and degradation processes, and improved awareness are the key factors supporting the rapid growth of the metallic bioabsorbable stent segment. Magnesium-based bioabsorbable stents are the most commonly used alloy stents because magnesium is an essential element for the human body. Magnesium allows rapid endothelialization and reduced thrombogenicity; in addition, magnesium alloy stents also have a reduced degradation time as compared to iron alloy bioabsorbable stents.

For the purpose of this study, the global market for bioabsorbable stents is studied for their application in the following areas:

  • Coronary artery diseases
  • Peripheral artery diseases

Coronary artery disease is one of the leading causes of death worldwide. Percutaneous transluminal coronary angioplasty is the major mechanical intervention used for treating coronary artery disease. Restenosis is the vascular expression of the response to injury. Recoiling of arteries during the healing process is a primary factor responsible for restenosis post-angioplasty. Stents offer mechanical scaffolding to the vessel, thus eliminating restenosis and vessel recoil. However, continuing the pressure from the stent against the vessel may result in neointimal tissue proliferation due to the stent and thus initiate the recurrence of luminal narrowing due to restenosis. Coronary intervention with bioabsorbable stents has developed renewed interest due to the fact that the need for mechanical support for the healing artery is temporary, and prolonged implantation results in disadvantages associated with permanent metallic prostheses.

Stents are beneficial in improving immediate treatment outcomes, including reducing acute vessel occlusion after percutaneous intervention by scaffolding. Scaffolds reduce restenosis by preventing negative remodeling. The potential advantages of having bioabsorbable stents in the treated site include a reduction in the incidence of late stent thrombosis, improved lesion imaging with MRI and CT, ease in performing repeat treatments at the same site, vasomotion restoration, and so on. Therefore, bioabsorbable stents in coronary artery diseases have a significant role in treating pediatric patients as they allow vessel growth and avoid future surgical procedures for stent removal.

For the purpose of this study, the global market for bioabsorbable stents is studied for the following end-users:

  • Hospitals
  • Ambulatory Surgical Centers

Between hospitals and ambulatory surgical centers, hospitals currently enjoy the dominant position in the bioabsorbable stents market worldwide. The availability of a wide range of procedure options, higher quality care, and greater patient foot traffic are the key factors contributing to the dominance of this segment. Furthermore, hospitals are a more viable option for patients with a wide range of health statuses. Conversely, it is expected that the trend toward preferring procedures being performed in ambulatory surgical centers will pick up the pace during the forecast period.

Reduced care time in the facility, lower infection rates, lower procedure costs, and increased patient convenience will drive the growth of this segment. Procedures in ambulatory centers take about 20% to 25% less time than in hospitals, thus exhibiting the potential that such organizations can provide more procedures and thus generate more revenue. Reduced hospital stays also lead to significant savings for insurance providers and patients alike. Further improvements in the nature of minimally invasive surgical technologies will contribute to the growing prominence of ambulatory surgical centers in the market.

Geographically, the global bioabsorbable stents market is cumulative for North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.North America is the current leader in the global bioabsorbable stents market in terms of both procedure rate and revenue. The early introduction of breakthrough products in the U.S. market, greater awareness between both patients and physicians, an evolved reimbursement scenario, and a robust healthcare system are the key factors supporting the dominance of the North American market.

Increased prevalence of coronary artery disease and peripheral artery disease also contributes significantly to increased demand for bioabsorbable stents in the North American and European markets. Additionally, it is expected that the Asia-Pacific market will witness the fastest growth during the forecast period. Exponential growth in the patient pool with chronic peripheral vascular and cardiac diseases, a large population base, increasing patient preference for safer minimally invasive procedures, and improving disposable incomes, along with the rapid evolution of healthcare infrastructure, will play a key role in driving the growth of the Asia Pacific bioabsorbable stents market. In addition, an increase in the number of ambulatory surgical centers being established, along with growing awareness about the associated benefits, will also facilitate the growth of the bioabsorbable stents market in the Asia Pacific.

The detailed regional classification of the global bioabsorbable stent market is as follows:

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, and the Rest of Europe)
  • Asia Pacific (China, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa) 

Frequently Asked Question:

The market for Bioabsorbable Stents Market is expected to reach USD$ 511.1 Mn in 2025.

The Bioabsorbable Stents Market is expected to see significant CAGR growth over the coming years, at 10.1%.

The report is forecasted to 2017-2025.

The base year of this report is 2016.

Arterial Remodeling Technologies, Arterius Limited, B. Braun Melsungen AG, Boston Scientific Corporation, C.R. Bard, Inc., Elixir Medical Corporation, Kyoto Medical Planning Co. are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Nov 2017
Category:  Medical Devices
Report ID:   58790
Report Format:   PDF
Pages:   120
Rating:    4.8 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support